Advertisement
Advertisement
OMCL
Omnicell Inc
36.16
USDSponsored
-1.01
-2.72%
Aug 06, 16:00 UTC -4
Closed
Pre-Market
36.16
0.00
0.00%
OMCL Earnings Reports
Positive Surprise Ratio
OMCL beat 34 of 42 last estimates.
81%
Next Report
Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$315.22M
/$0.46
Implied change from Q2 26 (Revenue/ EPS)
+0.96%
/-51.06%
Implied change from Q3 25 (Revenue/ EPS)
+0.39%
/+15.00%
Omnicell Inc earnings per share and revenue
On Jul 30, 2026, OMCL reported earnings of 0.94 USD per share (EPS) for Q2 26, beating the estimate of 0.47 USD, resulting in a 97.11% surprise. Revenue reached 312.21 million, compared to an expected 316.46 million, with a -1.34% difference. The market reacted with a -10.36% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of 0.46 USD, with revenue projected to reach 315.22 million USD, implying an decrease of -51.06% EPS, and increase of 0.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.86
Actual
$0.90
Surprise
+3.97%
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
Evolent Health, Inc Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.02
Surprise
+183.68%
CareCloud, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.06
Actual
$0.06
Surprise
-7.12%
Nyxoah SA Ordinary Shares
Report Date
Aug 05, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.57
Surprise
-46.96%
Outset Medical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.80
Surprise
-7.87%
Health Catalyst, Inc Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.02
Actual
$0.04
Surprise
+45.45%
Doximity, Inc.
Report Date
Aug 06, 2026 For Q1 27
Estimate
$0.31
Actual
$0.28
Surprise
-6.66%
iRhythm Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.57
Surprise
+12,988.89%
10x Genomics, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.14
Surprise
+43.09%
FAQ
What were Omnicell Inc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Omnicell Inc reported EPS of $0.94, beating estimates by 97.11%, and revenue of $312.21M, -1.34% below expectations.
How did the market react to Omnicell Inc's Q2 2026 earnings?
The stock price moved down -10.36%, changed from $41.40 before the earnings release to $37.11 the day after.
When is Omnicell Inc expected to report next?
The next earning report is scheduled for Oct 28, 2026.
What are the forecasts for Omnicell Inc's next earnings report?
Based on 9
analysts, Omnicell Inc is expected to report EPS of $0.46 and revenue of $315.22M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement